美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Correvio Pharma Corp.

0.4199

0.0000

成交量：- -

成交額：- -

市值：2,779.38萬

市盈率：-0.53

高：0.4199

開：0.4199

低：0.4199

收：0.4199

52周最高：2.79

52周最低：0.2100

股本：6,619.15萬

流通股本：6,501.11萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.7947

每股收益(LYR):-0.7947

淨資產收益率：-1158.13%

總資產收益率：-28.95%

市淨率：18.07

市盈率(LYR):-0.53

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Correvio Pharma Corp.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.correvio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Correvio Pharma Corp.是根據公司法（不列顛哥倫比亞省）於1986年12月12日在Nortran資源有限公司的名義下註冊成立。 Cardiome製藥公司是一家生物製藥公司，致力於改善世界各地患者的健康新療法的發現、開發和商業化。公司擁有一個產品，BRINAVESS，在成人中快速的新近發生竇性心律的心房顫動轉化，在歐洲和其他地區批准上市。公司的主導臨床方案也集中在心髒的上腔治療心房顫動上，也叫心律失常（或節律異常）。公司擁有幾個臨床前項目，針對各種治療適應症，其中有一個未滿足的醫療需要。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CORV/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"CORV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORV\",,,,,undefined,":{"symbol":"CORV","market":"US","secType":"STK","nameCN":"Correvio Pharma Corp.","latestPrice":0.4199,"timestamp":1590523200000,"preClose":0.4199,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":65011067,"shares":66191487,"eps":-0.794655,"marketStatus":"停牌","change":0,"latestTime":"05-26 16:00:00 EDT","open":0.4199,"high":0.4199,"low":0.4199,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.794655,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.4199,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORV\",,,,,undefined,":{"symbol":"CORV","floatShares":65011067,"roa":"-28.95%","roe":"-1158.13%","lyrEps":-0.794655,"shares":66191487,"dividePrice":0,"high":0.4199,"amplitude":0,"preClose":0.4199,"low":0.4199,"week52Low":0.21,"pbRate":"18.07","week52High":2.79,"institutionHeld":0.1341,"latestPrice":0.4199,"eps":-0.794655,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.794655,"open":0.4199,"prevYearClose":0.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-03-30","symbol":"CORV","fiscalQuarterEnding":"2019/12","expectedEps":-0.13,"name":null,"time":"","type":"earning","dateTimestamp":1585540800000,"reportTimeType":"","actualEps":-0.1},{"date":"2019-11-14","symbol":"CORV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.17,"defaultRemindTime":1573722000000,"name":null,"time":"盤前","dateTimestamp":1573707600000,"actualEps":-0.2},{"date":"2019-08-14","symbol":"CORV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.21,"defaultRemindTime":1565769600000,"name":null,"time":"盤前","dateTimestamp":1565755200000,"actualEps":-0.37},{"market":"US","date":"2019-05-08","symbol":"CORV","fiscalQuarterEnding":"2019/03","expectedEps":-0.19,"name":null,"time":"盤前","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2019-03-13","symbol":"CORV","fiscalQuarterEnding":"2018/12","expectedEps":-0.19,"name":null,"time":"盤前","type":"earning","dateTimestamp":1552449600000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORV\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.correvio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Correvio Pharma Corp.是根據公司法（不列顛哥倫比亞省）於1986年12月12日在Nortran資源有限公司的名義下註冊成立。 Cardiome製藥公司是一家生物製藥公司，致力於改善世界各地患者的健康新療法的發現、開發和商業化。公司擁有一個產品，BRINAVESS，在成人中快速的新近發生竇性心律的心房顫動轉化，在歐洲和其他地區批准上市。公司的主導臨床方案也集中在心髒的上腔治療心房顫動上，也叫心律失常（或節律異常）。公司擁有幾個臨床前項目，針對各種治療適應症，其中有一個未滿足的醫療需要。","exchange":"NASDAQ","name":"Correvio Pharma Corp.","nameEN":"Correvio Pharma Corp."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CORV\",market:\"US\",,,undefined,":null}}